Zopiclone clinical trials
Also written Imovane.
How each study uses zopiclone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
18 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 12
Taisho Pharmaceutical Co., Ltd. (2) · St. Olavs Hospital (2) · Janssen Research & Development, LLC (1) · Western University, Canada (1) · Idorsia Pharmaceuticals Ltd. (1) · I.M. Sechenov First Moscow State Medical University (1) · Eisai Inc. (1) · OSR Medical Inc. (1)
Often tested with
Tested in the same studies.
TS-142 (2) · Gabapentin (2) · Doxepin (2) · Alprazolam (2) · Seltorexant (1) · Celecoxib (1) · Daridorexant (1) · Lemborexant (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypnotics and Sedatives source
Studies
Open first, then newest update. How each study uses zopiclone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 18
- A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive DisorderCompletedPhase 1Janssen Research & Development, LLCNCT04451187Written as ZopicloneHow we know
- A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT05819710Written as ZopicloneHow we know
- A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04696952Written as ZopicloneHow we know
- Efficacy of Multimodal Analgesia Following Hip ArthroscopyCompletedNot applicableWestern University, CanadaNCT03351439Written as ZopicloneHow we know
- Pharmacological Treatment of Insomnia in Palliative CareCompletedPhase 4St. Olavs HospitalNCT02807922Written as ZopicloneHow we know
- Benefit of One Month Zopiclone Intake on Adaptative Servoventilation ComplianceTerminatedPhase 4University Hospital, GrenobleNCT02820441Written as ZopicloneHow we know
- A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly SubjectsCompletedPhase 1Idorsia Pharmaceuticals Ltd.NCT03892902Written as Zopiclone 7.5 mgHow we know
- Effectiveness of BBT-I and Zopiclone for Chronic InsomniaCompletedPhase 2I.M. Sechenov First Moscow State Medical UniversityNCT03339583Written as ZopicloneHow we know
- Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly SubjectsCompletedPhase 1Eisai Inc.NCT02583451Written as Zopiclone 7.5 mgHow we know
- Hangover and Residual Zopiclone Effect on Spatial PerceptionStatus unknownPhase 1Petri VainioNCT03632408Written as ZopicloneHow we know
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as ZopicloneHow we know
- Effect of Zopiclone on Compliance With Continuous Positive Airway Pressure in Obstructive Sleep ApneaCompletedPhase 3OSR Medical Inc.NCT01369576Written as ZopicloneHow we know
- Treatments for Insomnia in Patients With Parkinson's DiseaseCompletedEarly Phase 1McGill University Health Centre/Research Institute of the McGill University Health CentreNCT01489982Written as Doxepin and ZopicloneHow we know
- Driving Simulator Performance After Intake of Zopiclone Sleeping PillsWithdrawnNot applicableSt. Olavs HospitalNCT01257165Written as ZopicloneHow we know
- Reassessment of Premedication in SurgeryCompletedPhase 4University Hospital, AngersNCT01549691Written as ZopicloneHow we know
- Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in COPD PatientsCompletedNot applicableLHL HelseNCT00888342Written as zopicloneHow we know
- Cognitive-Behavioural and Hypnotic Treatment of Chronic Primary Insomnia Among the ElderlyCompletedPhase 4University of BergenNCT00295386Written as ZopicloneHow we know
- Effects of Ramelteon on Driving AbilityCompletedPhase 1Utrecht Institute for Pharmaceutical SciencesNCT00319215Written as Zopiclone 7.5 mgHow we know
Given beside what is tested · 2 — zopiclone is usual care or a partner of the new treatment
- A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy WomenCompletedPhase 1BayerNCT06219902Written as ZopicloneHow we know
- SleepSure: A Trial to Assess the Effects of Eye Masks and Earplugs on Hospital Inpatient SleepCompletedPhase 3Oxford University Hospitals NHS TrustNCT02732912Written as ZopicloneHow we know
As the comparator · 5 — what is tested is compared with zopiclone
- A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)CompletedPhase 1Merck Sharp & Dohme LLCNCT01311882Written as ZopicloneHow we know
- A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)CompletedPhase 1Merck Sharp & Dohme LLCNCT00798395Written as zopicloneHow we know
- A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of InsomniaCompletedPhase 3Eurofarma Laboratorios S.A.NCT01100164Written as ZopicloneHow we know
- Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual TabletCompletedPhase 1Transcept PharmaceuticalsNCT01106859Written as zopicloneHow we know
- Safety and Efficacy of Ramelteon in Adults With Chronic InsomniaCompletedPhase 3TakedaNCT00237497Written as ZopicloneHow we know
Codes
What other systems call zopiclone · ClinicalTrials.gg INT004994
- MeSH (NLM) C515050zopicloneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 03A5ORL08QZOPICLONEConfirmed FDA, NLM, Wikidata
- RxNorm 40001Confirmed FDA, Wikidata
- Wikidata Q220426zopicloneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C80279ZopicloneOne source FDA
- DrugBank DB01198One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C515050 | zopiclone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 03A5ORL08Q | ZOPICLONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 40001 | — | Confirmed FDA, Wikidata |
| Wikidata | Q220426 | zopiclone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C80279 | Zopiclone | One source FDA |
| DrugBank | DB01198 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.